Stay updated on EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Sign up to get notified when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now indicates that the study has increased to 12 locations, including a specific site in Lyon, France, and has updated the relevant dates.
    Difference
    0.7%
    Check dated 2025-05-08T04:46:57.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T00:20:35.000Z thumbnail image
  3. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to reflect changes in the study protocol for the Phase III trial of alpelisib in combination with trastuzumab and pertuzumab for HER2-positive advanced breast cancer, including the confirmation of the recommended phase 3 dose and the unblinding of participants in Part 2 of the study.
    Difference
    26%
    Check dated 2025-04-16T14:51:23.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 7, 2025.
    Difference
    0.3%
    Check dated 2025-04-09T10:26:40.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:40:55.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T21:22:47.000Z thumbnail image

Stay in the know with updates to EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.